| NuvaRing
Cycle Control and Tolerability |
|
|
|
|
|
|
|
|
|
|
|
| n | Good cycle
control |
|||||||||
| n | Irregular
bleeding was rare |
|||||||||
| (2.6% - 6.4% of
evaluable cycles) |
||||||||||
| n | Withdrawal
bleeding occurred |
|||||||||
| (97.9% - 99.4%
of evaluable cycles) |
||||||||||
| n | Well tolerated
and well accepted by users and their |
|||||||||
| partners (only
5% of partners objected to use) |
||||||||||
| Roumen FJ, et al. Hum
Reprod. 2001;16:469-475. |
